0

Purchase Short-Term Access

Evaluating Off-Label Uses of Anticancer Drugs: Time for a Change
Harold C. Sox, MD, Editor
Annals of Internal Medicine 2009;150:353-354. doi:10.7326/0003-4819-150-5-200903030-00110

Purchase Online access to this article for 24 hours
Buy Now

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)